Claim · 2024-01-07 · snapshot · Stated in source · Supported

Isomorphic Labs' January 2024 release names Demis Hassabis as "CEO and founder of Isomorphic Labs".

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

Demis Hassabis → held role at → Isomorphic Labs

Where it appears

No collection page holds this claim. It is listed with its records in the explorer.

Claim and evidence

Demis Hassabisheld role at ↓Isomorphic Labs

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: primary · 1 source; Context: primary · 1 source

Date: 2024-01-07 · snapshot Records dated 2024 →
Role: CEO and founder

Scope and limitsA dated role snapshot. The launch article's statement in the author's voice about serving as CEO is not used because the page names no author. The company's team page of 2026-10-30 lists "Sir Demis Hassabis, PhD" as "Founder and CEO" (context). Existing dataset records cover his DeepMind, Google DeepMind and Alphabet roles.

The evidence 02

primary sourceSupports the claim

Isomorphic Labs announces strategic multi-target research collaboration with Lilly

Isomorphic Labs · 2024-01-07

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“said Demis Hassabis, CEO and founder of Isomorphic Labs”

Location in source PDF p. 1, quotation attribution

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Isomorphic Labs
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 b98516157887ccc70377a9e83bccf3caec3de1dfa3838bfe63719cde10092b4b). PDF news release dated January 7, 2024, linked from the Isomorphic Labs article of that date; retrieved 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Isomorphic Labs, “Isomorphic Labs announces strategic multi-target research collaboration with Lilly”, 2024-01-07.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (9 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. A cross-family machine check (2026-10-30, item A42) answered the record’s question blind from fresh retrievals and agreed with the record. No human editorial review.

primary sourceContext only

Our Team

Isomorphic Labs · Publication date unknown

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“Sir Demis Hassabis, PhD Founder and CEO”

Location in source Leadership Team

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Isomorphic Labs
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 4ecada823eeef4c6dddba0f9cad07126fad5ed25cdd1c0aad3bb776baa99c2f7). Leadership page as served on 2026-10-30 (undated: snapshot). Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Isomorphic Labs, “Our Team”.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (7 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. Later snapshot (2026-10-30), shown for continuity of the stated title only. A cross-family machine check (2026-10-30, item A42) answered the record’s question blind from fresh retrievals and agreed with the record. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. An institutional role with explicitly scoped time: snapshot, sourced interval, or unknown dates. No continuing appointment is implied.

Date. Source-dated snapshot; no start, end or continuing role is inferred.

Record ID aib-labs-hassabis-iso-ceo-2024